Kura Oncology, Inc. (KURA)

Kura Oncology, Inc. in the Healthcare sector is trading at $9.82 with a market capitalization of $1.0B. Wall Street consensus targets $31.85 (13 analysts), implying a +224.3% move over the next 12 months. The stock is currently 29% below its 52-week high of $13.90, remaining 0.2% above its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 22 is oversold, raising the odds of a near-term bounce. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.